Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Netherton Syndrome
Netherton Syndrome
Microbiome Report for Week Ending 4/13/19
Microbiome Report for Week Ending 4/13/19
CP Wire
MaaT Pharma
MaaT013
aGvHD
Second Genome
SkinBio Therapeutics
Azitram AZT-02
Netherton Syndrome
Flag link:
Microbiome Report for Week Ending 4/13/19
MaaT Pharma
MaaT013
aGvHD
Second Genome
SkinBio Therapeutics
Azitram AZT-02
Netherton Syndrome
Flag link:
Azitra Demonstrates Feasibility of Using the Skin Microbiome to Treat Skin Conditions
Azitra Demonstrates Feasibility of Using the Skin Microbiome to Treat Skin Conditions
CP Wire
Azitra
Netherton Syndrome
microbiome
skin microbiome
Flag link:
Azitra Demonstrates Feasibility of Using the Skin Microbiome to Treat Skin Conditions
Azitra
Netherton Syndrome
Flag link:
LifeMax Acquires Rights to Orphan Drug for Netherton Syndrome from Novartis
LifeMax Acquires Rights to Orphan Drug for Netherton Syndrome from Novartis
CP Wire
LifeMax Laboratories
Novartis
BPR277
Netherton Syndrome
Flag link:
LifeMax Acquires Rights to Orphan Drug for Netherton Syndrome from Novartis
LifeMax Laboratories
Novartis
BPR277
Netherton Syndrome
Flag link: